Revenue: $94,296 for QQ1 2026, YoY growth +238.66%, QoQ growth +207.25%. Gross profit and gross margin are not disclosed in the provided data. Operating income: -$662,124, margin -7.02%. Net income: -$642,266, margin -6.81%. EBITDA: -$662,124, EBITDA margin -7.02%. EPS: -$0.14. R&D: $102,888; SG&A: $547,060; Selling & Marketing: $106,472; SG&A + R&D = $653,532; total operating expenses: $756,420. Cash from operations: -$415,765; Free cash flow: -$415,765. Cash and cash equivalents: $1,830,053; total cash at period-end: $1,930,053. Balance sheet: total assets $2,596,126; total current assets $1,905,726; total current liabilities $427,637; total liabilities $427,637; total stockholders’ equity $2,168,489; retained earnings negative at -$42,092,853; non-current assets include other non-current assets of $657,301 and substantial other stockholders’ equity of $44,260,884.